ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 5 filers reported holding ALBIREO PHARMA INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $48 | -99.7% | 1,080 | -99.8% | 0.00% | -100.0% |
| Q4 2022 | $13,716 | -99.9% | 634,701 | -1.4% | 0.14% | +0.7% |
| Q3 2022 | $12,464,000 | +90.9% | 643,792 | +95.9% | 0.14% | +97.1% |
| Q2 2022 | $6,528,000 | -30.8% | 328,678 | +4.0% | 0.07% | -16.7% |
| Q1 2022 | $9,432,000 | +24.1% | 316,183 | -3.1% | 0.08% | +31.2% |
| Q4 2021 | $7,599,000 | -5.7% | 326,290 | +26.3% | 0.06% | -11.1% |
| Q3 2021 | $8,061,000 | +7.6% | 258,381 | +21.4% | 0.07% | +10.8% |
| Q2 2021 | $7,490,000 | -1.9% | 212,904 | -1.7% | 0.06% | -7.1% |
| Q1 2021 | $7,636,000 | -0.8% | 216,634 | +5.6% | 0.07% | -13.6% |
| Q4 2020 | $7,698,000 | +51.3% | 205,226 | +34.6% | 0.08% | +20.9% |
| Q3 2020 | $5,087,000 | – | 152,455 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 491,244 | $9,510,000 | 5.10% |
| Decheng Capital Management III (Cayman), LLC | 623,342 | $12,068,000 | 4.38% |
| TANG CAPITAL MANAGEMENT LLC | 1,099,516 | $21,287,000 | 2.61% |
| Privium Fund Management B.V. | 300,252 | $5,624,000 | 2.04% |
| Birchview Capital, LP | 117,000 | $2,265,000 | 1.60% |
| Perceptive Advisors | 2,360,139 | $45,692,000 | 1.33% |
| Chicago Capital, LLC | 1,119,774 | $21,679,000 | 1.25% |
| Endurant Capital Management LP | 172,621 | $3,342,000 | 1.09% |
| Deep Track Capital, LP | 1,110,624 | $21,502,000 | 0.98% |
| SPHERA FUNDS MANAGEMENT LTD. | 359,000 | $6,950,000 | 0.96% |